Richard Peters

Non-executive chair bij Pharming Group

Personalia

Naam: Richard Peters

Nationaliteit: Belgische

Is dit uw profiel en heeft u vragen, opmerkingen of wijzigingen? Neem dan contact met ons op. Contact

Huidige functies Richard Peters

2023 - heden Non-executive chair, Pharming Group
2019 - heden Oprichter & executive chair, TellBio

Loopbaan Richard Peters

2019 - 2022 President & CEO, Yumanity Therapeutics
2016 - 2022 Oprichter & director, PIC Therapeutics
2019 - 2021 Corporate advisor, Merrimack Pharmaceuticals
2017 - 2019 President, CEO & director, Merrimack Pharmaceuticals
2015 - 2017 Senior vice president, head of global rare diseases & JAPAC specialty care BU head, Sanofi Genzyme
2014 - 2015 Mede-oprichter, investeerder & director, X4 Pharmaceuticals
2014 - 2014 Strategy development officer, Gemzyme
2011 - 2014 Division medical officer, Sanofi
2008 - 2011 Vice president, global & US medical affairs, Genzyme
2006 - 2008 Senior director medical affairs, Onyx Pharmaceuticals
2003 - 2006 Director medical affairs, Amgen
1997 - 2003 CEO, Mednav
1993 - 1997 Docent geneeskunde, Massachusetts General Hospital

Opleiding Richard Peters

Farmacologie, Medical University of South Carolina
Howard Hughes postdoctorale opleiding, Harvard Medical School
Geneeskunde, Massachusetts General Hospital

Is dit uw profiel en heeft u vragen, opmerkingen of wijzigingen? Neem dan contact met ons op.

Overige vermeldingen

Overige nevenfuncties
- Non-executive director, Kineta (sinds 2022)
- Non-executive director, Aprea Therapeutics (sinds 2020)
- Investor & corporate advisor, Aura Biosciences (sinds 2014)